Genetic deletion of Lcn2 or injections of a NGAL neutralizing antibody protected against abdominal aortic aneurysm, with lower neutrophil infiltration and diminished MMP activity [23]. This evidence concerns the gene LCN2 and abdominal aortic aneurysm.